Emergency Preparedness & Response
- Specific Hazards
- Bioterrorism
- A–Z
- Anthrax
- What You Need To Know
- Mail Handlers
- Questions & Answers
- Additional Fact Sheets & Overviews
- Cutaneous Anthrax
- Diagnosis
- Environment
- Exposure Management
- Infection Control
- Lab Testing
- Images
- Preparation & Planning
- References
- Surveillance & Investigation
- Training & Education
- Treatment
- Vaccination
- Work Safety
- Arenaviruses
- Botulism
- Brucella
- Cholera
- Ebola virus
- E. coli
- Food safety threats
- Glanders
- Lassa fever
- Marburg virus
- Melioidosis
- Plague
- Q fever
- Salmonella
- Shigella
- Smallpox
- Smallpox Basics
- Vaccine Basics
- Clinicians
- Vaccination Q & A (for professionals)
- Health Officials
- People Selected for Response Teams
- Diagnosis/
Evaluation - Lab Testing
- Infection Control
- Surveillance & Investigation
- Preparation & Planning
- Response
- Vaccination
- Images
- Medical Management
- Training & Education
- References
- Tularemia
- Typhoid fever
- Viral hemorrhagic fevers
- Anthrax
- List by Category
- Fact Sheets
- Case Definitions
- Training
- Surveillance
- Preparation & Planning
- First Responders
- Lab Info
- A–Z
- Chemical
- A–Z
- Abrin
- Adamsite
- Ammonia
- Arsenic
- Arsine
- Barium
- Benzene
- Brevetoxin
- Bromine
- BZ
- Carbon monoxide
- Chlorine
- Chromium
- Colchicine
- Cyanide
- Digitalis
- Ethylene glycol
- Hydrazine
- Hydrofluoric acid
- Hydrogen chloride
- Lewisite
- Melamine
- Mercury
- Methyl bromide
- Methyl isocyanate
- Nicotine
- Nitrogen mustard
- Opioids
- Organic solvents
- Osmium tetroxide
- Paraquat
- Phosgene
- Phosgene oxime
- Phosphine
- Phosphorus
- Ricin
- Sarin
- Saxitoxin
- Selenium
- Sodium azide
- Sodium monofluoroacetate
- Soman
- Strychnine
- Sulfur mustard
- Sulfuryl Fluoride
- Super Warfarin
- Tabun
- Tetrodotoxin
- Thallium
- Trichothecene
- Unidentified Chemical
- VX
- List by Category
- Chemical-Specific Fact Sheets
- Toxicology FAQs
- Case Definitions
- Toxic Syndrome Descriptions
- Toxicological Profiles
- Training
- First Responders
- Medical Management
- Emergency Response Cards
- Lab Info
- Surveillance
- Preparation & Planning
- A–Z
- Gulf Oil Spill 2010
- Radiation
- Mass Casualties
- Natural Disasters & Severe Weather
- Recent Outbreaks & Incidents
- Bioterrorism
- Preparedness for All Hazards
- Children
- Clinician Resources
- About COCA
- COCA Partner Organizations
- COCA Conference Calls
- Conference Calls - 2013
- Conference Calls - 2012
- Conference Calls - 2011
- Conference Calls - 2010
- June 3, 2010
- June 9, 2010
- June 22, 2010
- July 8, 2010
- July 27, 2010
- August 3, 2010
- August 17, 2010
- August 30, 2010
- September 2, 2010
- September 16, 2010
- September 21, 2010
- September 22, 2010
- October 1, 2010
- November 2, 2010
- November 9, 2010
- November 23, 2010
- December 2, 2010
- December 7, 2010
- December 14, 2010
- December 15, 2010
- Continuing Education Credit for COCA Calls
- Updates & Reminders
- Reminders - 2012
- Reminders - 2011
- Reminders - 2010
- Updates - 2013
- Updates - 2012
- January 3, 2012
- January 17, 2012
- January 30, 2012
- February 13, 2012
- February 27, 2012
- March 12, 2012
- March 26, 2012
- April 9, 2012
- April 23, 2012
- May 7, 2012
- May 21, 2012
- June 4, 2012
- June 18, 2012
- July 2, 2012
- July 16, 2012
- July 30, 2012
- August 13, 2012
- August 27, 2012
- September 10, 2012
- September 24, 2012
- October 8, 2012
- October 22, 2012
- November 5, 2012
- November 19, 2012
- December 3, 2012
- Updates - 2011
- January 3, 2011
- January 18, 2011
- January 31, 2011
- February 14, 2011
- February 28, 2011
- March 14, 2011
- March 21, 2011
- April 4, 2011
- April 11, 2011
- April 25, 2011
- May 9, 2011
- May 23, 2011
- June 6, 2011
- June 20, 2011
- July 5, 2011
- July 18, 2011
- August 1, 2011
- August 15, 2011
- August 29, 2011
- September 12, 2011
- September 26, 2011
- October 11, 2011
- November 7, 2011
- November 21, 2011
- December 5, 2011
- December 19, 2011
- Updates - 2010
- Join the COCA Mailing List
- Conference & Training Opportunities
- Emergency Preparedness and Response Training Resources
- Communicating in the First Hours
- Coping with a Disaster
- Crisis & Emergency Risk Communication (CERC)
- Health Alert Network (HAN)
- HAN Jurisdictions
- HAN Message Types
- Sign-Up for HAN Updates
- HAN Archive
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- HAN00219
- HAN00218
- HAN00217
- HAN00216
- HAN00215
- HAN00214
- HAN00213
- HAN00212
- HAN00211
- HAN00210
- HAN00209
- HAN00208
- HAN00207
- HAN00206
- HAN00205
- HAN00204
- HAN00203
- HAN00202
- HAN00201
- HAN00200
- HAN00199
- HAN00198
- HAN00197
- HAN00196
- HAN00195
- HAN00194
- HAN00193
- HAN00192
- HAN00191
- HAN00190
- HAN00189
- HAN00188
- HAN00187
- HAN00186
- HAN00185
- HAN00184
- HAN00183
- HAN00182
- HAN00181
- 2003
- HAN00180
- HAN00179
- HAN00178
- HAN00177
- HAN00176
- HAN00175
- HAN00174
- HAN00173
- HAN00172
- HAN00171
- HAN00170
- HAN00169
- HAN00168
- HAN00167
- HAN00166
- HAN00165
- HAN00164
- HAN00163
- HAN00162
- HAN00161
- HAN00160
- HAN00159
- HAN00158
- HAN00157
- HAN00156
- HAN00155
- HAN00154
- HAN00153
- HAN00152
- HAN00151
- HAN00150
- HAN00149
- HAN00148
- HAN00147
- HAN00146
- HAN00145
- HAN00144
- HAN00143
- HAN00142
- HAN00141
- HAN00140
- HAN00139
- HAN00138
- HAN00137
- HAN00136
- HAN00135
- HAN00134
- HAN00133
- HAN00132
- HAN00131
- HAN00130
- HAN00129
- HAN00128
- HAN00127
- HAN00126
- HAN00125
- HAN00124
- HAN00123
- HAN00122
- HAN00121
- HAN00120
- HAN00119
- HAN00118
- HAN00117
- HAN00116
- HAN00115
- HAN00114
- HAN00113
- HAN00112
- HAN00111
- HAN00110
- HAN00109
- HAN00108
- 2002
- HAN00107
- HAN00106
- HAN00105
- HAN00104
- HAN00103
- HAN00102
- HAN00101
- HAN00100
- HAN00099
- HAN00098
- HAN00097
- HAN00096
- HAN00095
- HAN00094
- HAN00093
- HAN00092
- HAN00091
- HAN00090
- HAN00089
- HAN00088
- HAN00087
- HAN00086
- HAN00085
- HAN00084
- HAN00083
- HAN00082
- HAN00081
- HAN00080
- HAN00079
- HAN00078
- HAN00077
- HAN00076
- HAN00075
- HAN00074
- HAN00073
- HAN00072
- HAN00071
- HAN00070
- HAN00069
- HAN00068
- HAN00067
- 2001
- HAN00066
- HAN00065
- HAN00064
- HAN00063
- HAN00062
- HAN00061
- HAN00060
- HAN00059
- HAN00058
- HAN00057
- HAN00056
- HAN00055
- HAN00054
- HAN00053
- HAN00052
- HAN00051
- HAN00050
- HAN00049
- HAN00048
- HAN00047
- HAN00046
- HAN00045
- HAN00044
- HAN00043
- HAN00042
- HAN00041
- HAN00040
- HAN00039
- HAN00038
- HAN00037
- HAN00036
- HAN00035
- HAN00034
- HAN00033
- HAN00032
- HAN00031
- HAN00030
- HAN00029
- HAN00028
- HAN00027
- HAN00025
- HAN00024
- HAN00023
- HAN00022
- HAN00021
- HAN00020
- HAN00019
- HAN00018
- HAN00017
- HAN00016
- HAN00015
- HAN00014
- HAN00013
- HAN00012
- HAN00011
- HAN00010
- HAN00009
- HAN00008
- HAN00007
- HAN00006
- HAN00005
- HAN00004
- HAN00003
- HAN00002
- HAN00001
- Lab Info
- Laboratory Response Network (LRN)
- Preparation & Planning
- Related Links
- Risk Communicator
- Issue 3
- Issue 2
- Priceless Collaboration for Hurricane Preparedness
- Talking to WHO's John Rainford - New WHO Guidelines
- Emergency Communication Challenges in Hurricane Katrina Response
- Hurricane Readiness in High-Risk Areas: Survey Results
- Elements of a Successful Exercise: Functional vs Tabletop and Beyond
- Collaboration & Communication During Emergency Response
- Public Health Observances
- Calendar of Training Opportunities
- Contributors
- Issue 1
- Introduction to the Risk Communicator
- Social Media & Emergency Communication
- Messaging Is Matter of Trust
- Program Spotlight: Frontlines of the CA Wildfires
- Research Summaries: Summaries of Work from Deborah Glik and Craig Lefebvre
- Risk Communication Opportunities During National Observances
- Upcoming Conferences, Training, and Workshops of Interest to Risk Communicators
- Contributors
- About the Newsletter
- SNAPS
- Social Media
- Surveillance
- Training & Education
- What CDC Is Doing
- What You Can Do
- Blog: Public Health Matters
- What's New
- A - Z Index
Patient Information:
Ciprofloxacin 500-mg Oral Tablet
Ciprofloxacin Oral Suspension
Take this medicine as prescribed.
Ciprofloxacin, commonly known as cipro, belongs to a class of drugs called quinolone antibiotics. It has been approved by the Food and Drug Administration (FDA) to treat and protect people who have been exposed to anthrax spores.
How to take cipro
ADULTS: Take 1 tablet every 12 hours as directed.
CHILDREN: A child’s dose depends on body weight. Give the medicine to your child as directed by the doctor.
It is best to take cipro 2 hours before or after a meal with at least one large glass of water. However, if an upset stomach occurs, cipro may be taken with food. Avoid dairy products such as milk and yogurt for at least 3 hours before and after taking the medicine. If you take vitamins or antacids such as Tums or Maalox, take them 6 hours before or 2 hours after taking cipro.
If you miss a dose, start again taking one tablet every 12 hours. Do not take 2 pills to make up for the missed dose. Finish all your pills, even if you feel okay, unless your doctor tells you to stop. If you stop taking this medicine too soon, you may become ill.
Side effects
Common side effects of cipro include an upset stomach, vomiting, diarrhea, fatigue, dizziness or headache. If you have problems with any of these symptoms, tell your doctor. Less common side effects include pain in arms or legs, changes in vision, restlessness, ringing in the ears, or mental changes. If any of these symptoms occur, call your doctor right away.
Severe allergic reactions are very rare. Signs of an allergic reaction include rash, itching, swelling of the tongue, hands or feet, fever, or trouble breathing. If any of these symptoms occur, call your doctor right away.
SPECIAL NOTE FOR CHILDREN: This medicine may cause joint problems in infants and children under 18 years of age. If your child has any joint pain while he/she is taking cipro, tell your doctor.
Precautions
- Be sure to tell the doctor if you are allergic to any medicine
- It is very important to tell your doctor about ALL of the medicine you are currently taking even pills that were bought at the store such as vitamins and antacids.
- Tell the doctor if you have ever had a seizure, stroke, or problems with your kidneys, joints or tendons, liver, or vision. Report any history of unusual bleeding or bruising.
- If this drug makes you dizzy, use caution driving or doing tasks that require you to be alert. Avoid alcohol in this case as it will make the dizziness worse.
- Cipro can make skin very sensitive to the sun which increases the chance of getting severe sunburn. Avoid the sun as much as possible. When outside, wear a long sleeve shirt and hat and always apply sunscreen (30 SPF)
- In women, cipro can cause vaginal itching and discharge commonly known as a yeast infection. Tell your doctor if this happens.
- If you are pregnant or breastfeeding, tell your doctor.
- Safety of taking cipro during pregnancy is unknown. If you are pregnant or could become pregnant, tell your doctor. Also, if you are breastfeeding, tell your doctor.
- Cipro can increase the effects of caffeine and theophylline (a medicine).
- Share
- Add this to...
- Favorites
- Del.icio.us
- Digg
- Google Bookmarks
- Technorati
- Yahoo MyWeb
- Updates
- Subscribe
- Listen
- Page last updated January 20, 2004
- Email page
- Print page
- Bookmark and share
- Add this to...
- Favorites
- Del.icio.us
- Digg
- Google Bookmarks
- Technorati
- Yahoo MyWeb
View page in
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO


